Atlas Arteria (ASX:ALX) EBIT: A$287.4 Mil (TTM As of Dec. 2025)


ASX:ALX Atlas Arteria Ltd ASX:ALX
75 GF Score
Price A$5.10
GF Value A$5.86
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Atlas Arteria EBIT?

Atlas Arteria ASX:ALX 75 EBIT is A$287.4 Mil as of Dec. 2025. GuruFocus rates ASX:ALX with a GF Score™ of 75/100 and a GF Value™ of A$5.86 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Atlas Arteria's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was A$160.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was A$287.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Atlas Arteria's annualized ROC % for the quarter that ended in Dec. 2025 was -0.51%. Atlas Arteria's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 2,200.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Atlas Arteria's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 2.49%.


Atlas Arteria  (ASX:ALX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Atlas Arteria's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-42 * ( 1 - 6.3% )/( (7783.9 + 7500.1)/ 2 )
=-39.354/7642
=-0.51 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Atlas Arteria's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=321.2/( ( (15 + max(-8.1, 0)) + (14.2 + max(-20, 0)) )/ 2 )
=321.2/( ( 15 + 14.2 )/ 2 )
=321.2/14.6
=2,200.00 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 11.5) - (0 + 0 + 19.6)
=-8.1

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.4 + 0 + 2.8) - (0 + 1.2 + 25)
=-20

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Atlas Arteria's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=287.4/11560.650
=2.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Atlas Arteria EBIT Related Terms


Atlas Arteria EBIT Historical Data

* Premium members only.

The historical data trend for Atlas Arteria's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atlas Arteria EBIT Chart

Atlas Arteria Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 259.28 335.16 356.50 373.30 287.40

Atlas Arteria Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 172.00 164.70 208.60 126.80 160.60

Atlas Arteria EBIT Competitor Comparison

For the Infrastructure Operations subindustry, Atlas Arteria's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atlas Arteria EV-to-EBIT vs Construction Industry

For the Construction industry and Industrials sector, Atlas Arteria's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Atlas Arteria's EV-to-EBIT falls into.


ASX:ALX
75GF Score
Atlas Arteria Ltd ASX:ALX
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atlas Arteria EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$287.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of A$287.4 Mil mean?
Atlas Arteria (ASX:ALX) has a EBIT of A$287.4 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Atlas Arteria.
Is Atlas Arteria's EBIT too high?
Atlas Arteria's current EBIT is A$287.4 Mil. Overall, Atlas Arteria has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Atlas Arteria's EBIT compare to competitors?
Atlas Arteria's EBIT of A$287.4 Mil can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Construction company?
A good EBIT depends on the Construction industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Atlas Arteria. Atlas Arteria's current EBIT is A$287.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atlas Arteria stock overvalued right now?
Based on GuruFocus' analysis, Atlas Arteria (ASX:ALX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$5.86, compared to a current price of A$5.10 — trading 13% below its estimated fair value. The current EBIT is A$287.4 Mil. Atlas Arteria's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Atlas Arteria (ASX:ALX), the current EBIT is A$287.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Atlas Arteria (ASX:ALX) Overvalued in 2026?

Based on GuruFocus' analysis, Atlas Arteria stock appears to be undervalued. The current stock price of A$5.10 is trading 13% below its estimated GF Value™ of A$5.86. GuruFocus considers Atlas Arteria to be Modestly Undervalued.

Key valuation signals for ASX:ALX:

  • EBIT: A$287.4 Mil
  • GF Value™: A$5.86 vs. price of A$5.10 (13% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the ASX:ALX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Atlas Arteria Business Description

Other Exchanges MAQAF:USAM82:Germany
Address 180 Flinders Street, Level 1, Melbourne, VIC, AUS, 3000
Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending by late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.
75GF Score

Get the complete analysis for ASX:ALX

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$5.10
Price
A$5.86
GF Value